Cargando…

Comprehensive Imaging Characterization of Colorectal Liver Metastases

Colorectal liver metastases (CRLM) have heterogenous histopathological and immunohistochemical phenotypes, which are associated with variable responses to treatment and outcomes. However, this information is usually only available after resection, and therefore of limited value in treatment planning...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maclean, Drew, Tsakok, Maria, Gleeson, Fergus, Breen, David J., Goldin, Robert, Primrose, John, Harris, Adrian, Franklin, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688250/ https://www.ncbi.nlm.nih.gov/pubmed/34950575 http://dx.doi.org/10.3389/fonc.2021.730854

Ejemplares similares

Surgery for colorectal liver metastases
por: Primrose, J N
Publicado: (2010)

Laparoscopic Hepatectomy for Colorectal Liver Metastases: The Current State of the Art
por: Sheen, Aali J., et al.
Publicado: (2019)

Gankyrin as Potential Biomarker for Colorectal Cancer With Occult Liver Metastases
por: Wang, Chengxing, et al.
Publicado: (2021)

B Cells as Prognostic Biomarker After Surgery for Colorectal Liver Metastases
por: Hof, Joost, et al.
Publicado: (2020)

Ablation or Resection for Colorectal Liver Metastases? A Systematic Review of the Literature
por: Kron, Philipp, et al.
Publicado: (2019)

Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver Metastases
por: Zhang, Tianhao, et al.
Publicado: (2021)

Dynamic radiomics for predicting the efficacy of antiangiogenic therapy in colorectal liver metastases
por: Qu, Hui, et al.
Publicado: (2023)

Meta-Analysis of Hepatic Arterial Infusion for Liver Metastases From Colorectal Cancer
por: Zhang, Yan, et al.
Publicado: (2021)

Systematic Review of the Prognostic Role of the Immune System After Surgery of Colorectal Liver Metastases
por: Hof, Joost, et al.
Publicado: (2019)

Comparison of Percutaneous Radiofrequency Ablation for Subcapsular and Non-Subcapsular Colorectal Cancer Liver Metastases
por: Fan, Hongjie, et al.
Publicado: (2021)

Value of sarcopenia in the resection of colorectal liver metastases—a systematic review and meta-analysis
por: Wagner, D., et al.
Publicado: (2023)

The molecular mechanisms underlying neutrophil infiltration in vessel co-opting colorectal cancer liver metastases
por: Rada, Miran, et al.
Publicado: (2022)

Prognosis of resectable colorectal liver metastases after surgery associated with pathological features of primary tumor
por: Chen, Dawei, et al.
Publicado: (2023)

The Role of the Immune Response in Brain Metastases: Novel Imaging Biomarkers for Immunotherapy
por: Zakaria, Rasheed, et al.
Publicado: (2021)

A Place for Radiofrequency Ablation in the Treatment of Resectable Colorectal Liver Metastases?
por: de Meijer, V. E., et al.
Publicado: (2008)

Mutated DNA Damage Repair Pathways Are Prognostic and Chemosensitivity Markers for Resected Colorectal Cancer Liver Metastases
por: Wang, Kun, et al.
Publicado: (2021)

Epithelial-Mesenchymal Transition in Colorectal Carcinoma: Comparison Between Primary Tumor, Lymph Node and Liver Metastases
por: Pavlič, Ana, et al.
Publicado: (2021)

Construction of a prognostic signature associated with liver metastases for prognosis and immune response prediction in colorectal cancer
por: Liu, Chang, et al.
Publicado: (2023)

Comprehensive characterization of FBXW7 mutational and clinicopathological profiles in human colorectal cancers
por: Liu, Yiping, et al.
Publicado: (2023)

T cells but not NK cells are associated with a favourable outcome for resected colorectal liver metastases
por: Pugh, Siân A, et al.
Publicado: (2014)

Prospective study of change in liver function and fat in patients with colorectal liver metastases undergoing preoperative chemotherapy: protocol for the CLiFF Study
por: Parmar, Kat L, et al.
Publicado: (2020)

Interventional radiological therapies in colorectal hepatic metastases
por: Vulasala, Sai Swarupa R., et al.
Publicado: (2023)

Stereotactic Body Radiation Therapy for Liver Metastases from Colorectal Cancer: Analysis of Safety, Feasibility, and Early Outcomes
por: Kress, Marie-Adele S., et al.
Publicado: (2012)

The Shifting Paradigm of Prognostic Factors of Colorectal Liver Metastases: From Tumor-Centered to Host Immune-Centered Factors
por: Donadon, Matteo, et al.
Publicado: (2018)

Low Concordance Between T-Cell Densities in Matched Primary Tumors and Liver Metastases in Microsatellite Stable Colorectal Cancer
por: Dagenborg, Vegar Johansen, et al.
Publicado: (2021)

A radiomic biomarker for prognosis of resected colorectal cancer liver metastases generalizes across MRI contrast agents
por: Chen, Jianan, et al.
Publicado: (2023)

3D Quantitative Ablation Margins for Prediction of Ablation Site Recurrence After Stereotactic Image-Guided Microwave Ablation of Colorectal Liver Metastases: A Multicenter Study
por: Ruiter, Simeon J. S., et al.
Publicado: (2021)

A Comprehensive Prognostic Model for Colorectal Cancer Liver Metastasis Recurrence After Neoadjuvant Chemotherapy
por: Zhou, Zhenyuan, et al.
Publicado: (2022)

Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy
por: Ye, Shuai, et al.
Publicado: (2022)

Automated segmentation of colorectal liver metastasis and liver ablation on contrast-enhanced CT images
por: Anderson, Brian M., et al.
Publicado: (2022)

An Analysis of Clinicopathological Outcomes and the Utility of Preoperative MRI for Patients Undergoing Resection of Mucinous and Non-Mucinous Colorectal Cancer Liver Metastases
por: Reynolds, Ian S., et al.
Publicado: (2022)

Prognostic Factors in Stage IV Colorectal Cancer Patients With Resection of Liver and/or Pulmonary Metastases: A Population-Based Cohort Study
por: Peng, Panxin, et al.
Publicado: (2022)

Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
por: Ye, Shuai, et al.
Publicado: (2023)

Conventional Two-Stage Hepatectomy or Associating Liver Partitioning and Portal Vein Ligation for Staged Hepatectomy for Colorectal Liver Metastases? A Systematic Review and Meta-Analysis
por: Zhang, Liang, et al.
Publicado: (2020)

Proof-of-Concept Pilot Study on Comprehensive Spatiotemporal Intra-Patient Heterogeneity for Colorectal Cancer With Liver Metastasis
por: Kyrochristos, Ioannis D., et al.
Publicado: (2022)

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
por: Raval, Mihir, et al.
Publicado: (2014)

Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the Challenges
por: Kranenburg, Onno, et al.
Publicado: (2021)

The difference of human gut microbiome in colorectal cancer with and without metastases
por: Sun, Leitao, et al.
Publicado: (2022)

Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?
por: Curley, Steven A.
Publicado: (2007)

Evaluation of colorectal cancer liver metastases based on liquid biopsy combined with folate receptor– Positive circulating tumor cells and HSP90
por: Huang, Maosen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2tdm6bk5iruqnsuidfdoqqjp9f